(Q41681569)

7 October 2017

1 reference

title

Pathobiology of acute and chronic hepatitis B virus infection: an introduction (English)

1 reference

7 October 2017

1 reference

1 reference

Milich DR

1

1 reference

7 October 2017

1 January 1997

1 reference

Journal of Viral Hepatitis

7 October 2017

1 reference

7 October 2017

4 Suppl 2

1 reference

7 October 2017

25-30

1 reference

Vertical Transmission of Hepatitis B Antigen in Taiwan

7 October 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

A signal peptide encoded within the precore region of hepatitis B virus directs the secretion of a heterogeneous population of e antigens in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

The serology of chronic hepatitis B infection revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Regulation of insulin-like growth factor II Gene expression by hepatitis B virus in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e–minus hepatitis B virus mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

DNA-mediated immunization in a transgenic mouse model of the hepatitis B surface antigen chronic carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

A case for cytokines as effector molecules in the resolution of virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Human T cell response to the surface antigen of hepatitis B virus (HBsAg). Endosomal and nonendosomal processing pathways are accessible to both endogenous and exogenous antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Expression and replication of hepatitis B virus genome in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.1997.TB00177.X

10.1111/J.1365-2893.1997.TB00177.X

21 January 2018

Identifiers

DOI

1 reference

7 October 2017

1 reference

PubMed ID

9429207